AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...

RAPT Therapeutics, Inc. is being acquired by GSK plc for $2.2B as ozureprubart targets IgE disorders with 8–12 week dosing.

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

With the Union Budget just around the corner, attention is firmly fixed on North Block as India's corporate sector looks for ...

Innovation aims to streamline research journey, positioning the university as a leader in ethical AI-driven scientific ...

IIT Guwahati hosts an international conference on Health Technology Assessment, focusing on evidence-based approaches for policy decisions ...

Column - There is no war of a regional or global scale that has not been originated by the Europeans, or that has not ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Bangladesh’s healthcare sector is expanding rapidly, yet public confidence continues to erode. Low public spending, uneven access, high out-of-pocket costs, and weak regulation have created a trust ...

Award-winning associate professor Emily Pentzer, Editor-in-Chief of RSC Applied Polymers, shares advice for authors.

The EMA validation of T-DXd with pertuzumab could change the standard of care for HER2-positive metastatic breast cancer in ...